Bruna Correa Lopes

Bruna Correa Lopes

Department of Small Animal Clinical Sciences, Texas A&M University, College Station, Texas, USA
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2019 in Tropical Animal Health and Production
Verified
Journal Article
Closed access
PDF file
RBRonaldo M. Bianchi
Ronaldo M. Bianchi
CSClaiton I. Schwertz
Claiton I. Schwertz
BCBianca S. de Cecco
Bianca S. de Cecco
WPWelden Panziera
Welden Panziera
CLCíntia De Lorenzo
Cíntia De Lorenzo
DDDavid Driemeier
David Driemeier

9 January 2024 in Animals
Verified
Journal Article
Open access
PDF file
Bruna Correa LopesBruna Correa Lopes
Bruna Correa Lopes
CCChih-Chun Chen
Chih-Chun Chen
CSChi-Hsuan Sung
Chi-Hsuan Sung
PIPatricia Eri Ishii
Patricia Eri Ishii
LMLuis Medina
Luis Medina
Rachel PillaRachel Pilla
Rachel Pilla
Bile acid metabolism is a key pathway modulated by intestinal microbiota. Peptacetobacter (Clostridium) hiranonis has been described as the main species responsible for the conversion of primary into secondary fecal unconjugated bile acids (fUBA) in dogs. This multi-step biochemical pathway is encoded by the bile acid-inducible (bai) operon. We aimed to assess the correlation between P. hiranonis abundance, the abundance of one specific gene of the bai operon (baiCD), and secondary fUBA concentrations. In this retrospective study, 133 fecal samples were analyzed from 24 dogs. The abundances of P. hiranonis and baiCD were determined using qPCR. The concentration of fUBA was measured by gas chromatography–mass spectrometry. The baiCD abundance exhibited a strong positive correlation with secondary fUBA (ρ = 0.7377, 95% CI (0.6461, 0.8084), p < 0.0001). Similarly, there was a strong correlation between P. hiranonis and secondary fUBA (ρ = 0.6658, 95% CI (0.5555, 0.7532), p < 0.0001). Animals displaying conversion of fUBA and lacking P. hiranonis were not observed. These results suggest P. hiranonis is the main converter of primary to secondary bile acids in dogs.

1 November 2021 in Journal of Comparative Pathology
Verified
Journal Article
Closed access
MSMônica Slaviero
Mônica Slaviero
LELuiza P. Ehlers
Luiza P. Ehlers
FAFernando F. Argenta
Fernando F. Argenta
CSCaroline Savi
Caroline Savi
Bruna Correa LopesBruna Correa Lopes
Bruna Correa Lopes
LSLuciana Sonne
Luciana Sonne

21 June 2024 in Frontiers in Veterinary Science
Verified
Journal Article
Open access
PDF file
AWAntja Watanangura
Antja Watanangura
SMSebastian Meller
Sebastian Meller
NFNareed Farhat
Nareed Farhat
JSJan S. Suchodolski
Jan S. Suchodolski
RPRachel Pilla
Rachel Pilla
HVHolger Volk
Holger Volk
Introduction: Anxiety and cognitive dysfunction are frequent, difficult to treat and burdensome comorbidities in human and canine epilepsy. Fecal microbiota transplantation (FMT) has been shown to modulate behavior in rodent models by altering the gastrointestinal microbiota (GIM). This study aims to investigate the beneficial effects of FMT on behavioral comorbidities in a canine translational model of epilepsy.Methods: Nine dogs with drug-resistant epilepsy (DRE) and behavioral comorbidities were recruited. The fecal donor had epilepsy with unremarkable behavior, which exhibited a complete response to phenobarbital, resulting in it being seizure-free long term. FMTs were performed three times, two weeks apart, and the dogs had follow-up visits at three and six months after FMTs. Comprehensive behavioral analysis, including formerly validated questionnaires and behavioral tests for attention deficit hyperactivity disorder (ADHD)- and fear- and anxiety-like behavior, as well as cognitive dysfunction, were conducted, followed by objective computational analysis. Blood samples were taken for the analysis of antiseizure drug (ASD) concentrations, hematology, and biochemistry. Urine neurotransmitter concentrations were measured. Fecal samples were subjected to analysis using shallow DNA shotgun sequencing, real-time polymerase chain reaction (qPCR)-based Dysbiosis Index (DI) assessment, and short-chain fatty acid (SCFA) quantification.Results: Following FMT, the patients showed improvement in ADHD-like behavior, fear- and anxiety-like behavior, and quality of life. The excitatory neurotransmitters aspartate and glutamate were decreased, while the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) and GABA/glutamate ratio were increased compared to baseline. Only minor taxonomic changes were observed, with a decrease in Firmicutes and a Blautia_A species, while a Ruminococcus species increased. Functional gene analysis, SCFA concentration, blood parameters, and ASD concentrations remained unchanged.Discussion: Behavioral comorbidities in canine IE could be alleviated by FMT. This study highlights FMT’s potential as a novel approach to improving behavioral comorbidities and enhancing the quality of life in canine patients with epilepsy.

1 January 2019 in Ciência Rural
Verified
Journal Article
Open access
PDF file
PTPaula Augusto Taunde
Paula Augusto Taunde
FAFernando Froner Argenta
Fernando Froner Argenta
RBRonaldo Michel Bianchi
Ronaldo Michel Bianchi
BCBianca Santana de Cecco
Bianca Santana de Cecco
AVAndréia Vielmo
Andréia Vielmo
DDDavid Driemeier
David Driemeier
This study described the epidemiological, clinical, pathological and bacteriological aspects of Mannheimia haemolytica pleuropneumonia in goats associated with shipping stress. Forty goats transported from the Northeast to the Southern region of Brazil died during shipment, or 2-3 days after unloading. Clinical signs included dyspnea, mucopurulent nasal discharge, and coughing. All goats were necropsied, and multiple tissues were collected for histopathological analysis and involved agent identifications. All lungs showed pulmonary consolidation, predominantly affecting the cranioventral lobes, in addition to the marked fibrinous pleuritis, pleural thickening, and pleural adhesions, that affected 90% of the goats. Histologically, there was fibrino-suppurative pleuropneumonia characterized by a diffuse neutrophilic infiltrate admixed with fibrin. Non-hemolytic [85% (34/40)] and hemolytic [15% (6/40)] species were obtained in bacteriological culture. Fir Mannheimia spp. was reported in 26 isolates and subsequently confirmed as M. haemolytica (99% identity), after amplification and partial sequencing of the 16S rDNA gene. Stress may trigger the development of bacterial pleuropneumonia in goats, and non-hemolytic strains of M. haemolytica may cause this condition in goats with severe immunosuppression.

17 April 2023 in Animals
Verified
Journal Article
Open access
PDF file
LTLinda Toresson
Linda Toresson
Jan SuchodolskiJan Suchodolski
Jan Suchodolski
TSThomas Spillman
Thomas Spillman
Bruna Correa LopesBruna Correa Lopes
Bruna Correa Lopes
JSJohnathan Shih
Johnathan Shih
Rachel PillaRachel Pilla
Rachel Pilla
Cobalamin deficiency is a common sequela of chronic enteropathies (CE) in dogs. Studies comparing the intestinal microbiome of CE dogs with cobalamin deficiency to those that are normocobalaminemic are lacking. Therefore, our aim was to describe the fecal microbiome in a prospective, comparative study evaluating 29 dogs with CE and cobalamin deficiency, 18 dogs with CE and normocobalaminemia, and 10 healthy control dogs. Dogs with cobalamin deficiency were also analyzed after oral or parenteral cobalamin supplementation. Overall microbiome composition (beta diversity) at baseline was significantly different in CE dogs with cobalamin deficiency when compared to those with normocobalaminemia (p = 0.001, R = 0.257) and to healthy controls (p = 0.001, R = 0.363). Abundances of Firmicutes and Actinobacteria were significantly increased (q = 0.010 and 0.049), while those of Bacteroidetes and Fusobacteria were significantly decreased (q = 0.002 and 0.014) in CE dogs with cobalamin deficiency when compared to healthy controls. Overall microbiome composition in follow-up samples remained significantly different after 3 months in both dogs receiving parenteral (R = 0.420, p = 0.013) or oral cobalamin supplementation (R = 0.251, p = 0.007). Because cobalamin supplementation, in combination with appropriate therapy, failed to restore the microbiome composition in the dogs in our study, cobalamin is unlikely to be the cause of those microbiome changes but rather an indicator of differences in underlying pathophysiology that do not influence clinical severity but result in a significant aggravation of dysbiosis.